Ignite Creation Date:
2024-05-06 @ 3:44 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02366026
Status:
UNKNOWN
Last Update Posted:
2016-02-23
First Post:
2015-02-06
Brief Title:
REMUNE AMPLIVAX IR103 HIVAIDS Phase III Safety Efficacy Study
Sponsor:
Immune Response BioPharma Inc
Organization:
Immune Response BioPharma Inc
Organization Data
Organization:
Immune Response BioPharma Inc
Class:
INDUSTRY
Study ID:
IR103-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Immune Response BioPharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None